May 29, 2026 05:04PM
May 20, 2026 11:06AM
May 4, 2026 05:22PM
Apr 10, 2026 07:00AM
Mar 17, 2026 07:00AM
Feb 20, 2026 07:00AM
Feb 17, 2026 07:00AM Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
Feb 10, 2026 07:00AM
Feb 4, 2026 07:00AM
Feb 2, 2026 07:00AM
Jan 12, 2026 07:00AM
May 30, 2025 07:00AM
May 20, 2025 07:00AM
May 5, 2025 07:00AM Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
Apr 10, 2025 07:00AM
Apr 7, 2025 07:00AM
Mar 12, 2025 07:00AM
Feb 10, 2025 07:00AM
Jan 27, 2025 04:15PM
Dec 9, 2024 08:05AM
Dec 5, 2024 07:00AM Theralase(R) Launches New Clinical Study Site in Canada
Nov 27, 2024 05:05PM
Oct 7, 2024 07:00AM
Aug 21, 2024 07:00AM
Aug 12, 2024 07:00AM
Jun 20, 2024 07:00AM
May 2, 2024 07:00AM
Mar 27, 2024 07:00AM Theralase(R) Release's 4Q2023 Interim Financial Statements
Feb 8, 2024 07:00AM
Nov 29, 2023 06:30PM
Oct 23, 2023 07:00AM
Oct 16, 2023 07:00AM
Aug 29, 2023 04:30PM
May 30, 2023 09:30PM
May 30, 2023 07:35PM Theralase(R) Releases 1Q2023 Interim Financial Statements
May 10, 2023 07:00AM
Apr 26, 2023 06:01PM
Nov 29, 2022 06:43PM
Aug 29, 2022 07:45PM
May 30, 2022 05:53PM
Apr 29, 2022 09:11PM
Apr 5, 2022 07:00AM Theralase® Provides Update on Phase II Bladder Cancer Clinical Study
Jun 11, 2021 07:00AM
May 28, 2021 06:58PM
Apr 28, 2021 07:00AM
Apr 27, 2021 07:00AM
Jan 20, 2021 07:00AM
Jan 19, 2021 07:00AM
Dec 7, 2020 07:00AM University of British Columbia Launched as Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Nov 27, 2020 10:15PM

323,124 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All